(Q43531967)

24 November 2017

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection (English)

1 reference

24 November 2017

1 reference

0 references

A Lafeuillade

1

1 reference

24 November 2017

G Hittinger

series ordinal

2

1 reference

24 November 2017

S Chadapaud

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

357

1 reference

24 November 2017

280-281

1 reference

24 November 2017

9252

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903618-7

7 January 2021

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903618-7

7 January 2021

Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903618-7

7 January 2021

Toxicologic effects of ribavirin in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903618-7

7 January 2021

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903618-7

7 January 2021

10.1016/S0140-6736(00)03618-7

Identifiers

DOI

1 reference

24 November 2017

1 reference